Researchers at the University of Iowa found that adding high-dose IV vitamin C to chemotherapy helped increase survival in ...

FOX 13's Allie Corey sat down with the chief of surgical oncology at TGH Institute and professor of surgery at USF Health as ...

Novocure’s positive phase 3 results boost pancreatic cancer treatment prospects. Read why NVCR stock is worth watching with ...

The therapy uses Tumor Treating Fields, or electric fields, to kill cancer cells while sparing most nearby healthy cells, ...

Patients with locally advanced pancreatic cancer demonstrated a two-month difference in survival with tumor-treating fields ...

A US Navy veteran who one day began having severe chest and back pain was diagnosed with stage 2 pancreatic cancer—one of the deadliest. According to doctors, the symptoms she had were completely ...

Pancreatic ductal adenocarcinoma (PDAC) is among the deadliest cancers, with a survival rate of just 11%. A primary culprit ...

FDA approves zenocutuzumab for advanced non-small-cell lung cancer and pancreatic cancer with NRG1 fusion, offering new hope ...

There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.

The phase 3 PANOVA-3 trial, designed to evaluate concomitant treatment with tumor treating fields and chemotherapy, met its ...

NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.

Dec 2 (Reuters) - Novocure (NVCR.O), opens new tab said on Monday its experimental therapy extended the lives of patients with a form of advanced pancreatic cancer when combined with chemotherapy ...